Prof. Dr. Gürkan Çelebi
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Helicobacter Infections 2 publicationsSource: OpenAlex / PubMed MeSHView publications
- Insulin Resistance 2 publications
- Liver Cirrhosis 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicalpark.com.tr.
- Mide hastalıkları
- Kalın bağırsak hastalıkları
- İltihabi bağırsak hastalıkları
- ERCP
- Pankreas safra yolları hastalıkları
- İleri endoskopik işlemler
- Yağlı karaciğer hastalığı
- Viral hepatitler
CV
Education and experience
Experience
- ExperienceGülhane Eğitim ve Araştırma Hastanesimedicalpark.com.tr
- ExperienceGATA Gastroenteroloji Ankaramedicalpark.com.tr
- ExperienceFoça 30 Yataklı İaşeli Özel Revir Baştabipliğimedicalpark.com.tr
- ExperienceGATA İç Hastalıkları Ankaramedicalpark.com.tr
- ExperienceTCG Barboros Revir Tabipliği Kocaelimedicalpark.com.tr
Education
- 19952002 Gülhane Askeri Tıp Fakültesimedicalpark.com.tr
- 20022005 TCG Barbaros Komutanlığı Revir Tabibimedicalpark.com.tr
- 20052010 GATA İç Hastalıkları Uzmanlık Eğitimimedicalpark.com.tr
- 20102011 30 Yataklı İaşeli Özel Revir İç Hastalıkları Uzmanı Foça-İzmirmedicalpark.com.tr
- 20112014 GATA Gastroenteroloji Yandal Uzmanlık Eğitimimedicalpark.com.tr
- 20142017 GATA Gastroenteroloji BD. Gastroenteroloji Uzmanımedicalpark.com.tr
- Education21.11. 2017 Doçentlik Unvanımedicalpark.com.tr
- 20172024 Gülhane Eğitim ve Araştırma Hastanesi Gastroenteroloji BD. Doçentmedicalpark.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyGastroenterologymedicalpark.com.trFrom source
- InstitutionMedical Park Ankara (Keçiören)medicalpark.com.trFrom source
- Area of workHelicobacter InfectionsExtracted from 2 publications · Model version —From source
- Publications40 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0003-3433-8221ORCIDFrom source
- Last synchronised4 November 2026 20:27https://www.medicalpark.com.tr/hekimler/gurkan-celebimedicalpark.com.tr
Scientific work
Publications on Helicobacter Infections
-
The prevalence and outcomes of inflammatory bowel disease among patients with cytomegalovirus disease
Gulhane Medical Journal, 2025
DOI 10.4274/gulhane.galenos.2024.59251 Open-access full textSource: OpenAlex
-
Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects
European Journal of Gastroenterology and Hepatology, 2024
DOI 10.1097/meg.0000000000002789 PMID 38829943 21 citations (Europe PMC) Source: ORCID
-
P506 Prevalance of the osteoporosis/osteopenia and related factors in patients with inflammatory bowel disease : An observational single-center study
Journal of Crohn s and Colitis, 2024
DOI 10.1093/ecco-jcc/jjad212.0636 2 citations (OpenAlex) Open-access full textSource: OpenAlex
-
The relationship of atherogenic index of plasma with endothelial dysfunction biomarkers in patients with metabolic associated fatty liver disease
Gulhane Medical Journal, 2022
DOI 10.4274/gulhane.galenos.2022.82905 2 citations (OpenAlex) Open-access full textSource: ORCID
-
Is the choice of anesthesia during gastrointestinal endoscopic procedures a result of anxiety?
Arab Journal of Gastroenterology, 2021
DOI 10.1016/j.ajg.2020.09.006 PMID 33551348 6 citations (Europe PMC) Source: OpenAlex
-
Betatrophin levels are related to the early histological findings in nonalcoholic fatty liver disease
Metabolites, 2021
DOI 10.3390/metabo11070425 PMID 34203342 6 citations (Europe PMC) Open-access full textSource: ORCID
-
COVID-19 Enfeksiyonunda Gastrointestinal Sistem Tutulumu ve Tedavisi Nedir?
Türkiye Klinikleri COVID - 19, 2021
Source: OpenAlex
-
Microvesicular steatosis: A missed item in the management of nonalcoholic fatty liver disease?
Acta Gastro-Enterologica Belgica, 2020
PMID 33321012 9 citations (OpenAlex) Source: ORCID
-
High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection
Turkish Journal of Gastroenterology, 2020
DOI 10.5152/tjg.2020.18974 PMID 32343235 14 citations (Europe PMC) Open-access full textSource: ORCID
-
Acute Exudative Diffuse Proliferative Glomerulonephritis in A Patient with Type 2 Diabetes Mellitus
DOAJ (DOAJ: Directory of Open Access Journals), 2019
Open-access full textSource: OpenAlex